Following a string of customer complaints, a Form 483 and a recall this past spring, a Fresenius manufacturing unit in Utah ...

Novartis is taking social media by storm with a multiple sclerosis (MS) campaign that urges patients to #KnowYourMS, a ...

While a positive advisory committee meeting seemed to up the odds of approval for Replimune’s twice-snubbed melanoma drug in ...

CMI Media Group is adding to its spread of media services through a new specialty communications business that introduces a ...

About two years ago, a head-to-head progression-free survival win made Akeso and Summit Therapeutics’ ivonescimab—and the ...

Repatha, also known as evolocumab, was first approved by the FDA in 2015 to help patients lower their LDL, or “bad,” ...

RNA-based vaccines and therapeutics may have faced a bumpy road in the U.S. recently, but a major new federal investment proves the government is still betting big on its future. | RNA-based vaccines ...

Novartis could cut around 130 jobs in Switzerland as it rethinks its biologics technical development and production footprint in Basel. | Novartis could cut about 130 jobs in Switzerland as it ...

Following a blow to the integrated contract developer and manufacturer’s client base, Cellares continues to move forward with ...

Since the launch of the Medicare GLP-1 Bridge on July 1, over 500,000 seniors have utilized the program and together saved ...

Kick-off for the 2027-2028 NFL football season is approaching, and with it will come a new slate of winners and losers in the pharma ad space. Ahead of the upcoming season, TV outcomes company EDO is ...

Genentech performance marketing engagement lead Tiffany William is a self-proclaimed “newbie” in pharma marketing.  | After ...